• Verteporfin: Atomic Mechanisms and Benchmarks in Photodyn...

  2026-01-21

  Verteporfin is a second-generation photosensitizer for photodynamic therapy (PDT) with proven efficacy in ocular neovascularization and emerging roles as an autophagy inhibitor. This article details Verteporfin's atomic mechanisms, evidence-based benchmarks, and workflow integration for researchers in age-related macular degeneration and cancer studies.

• PD0325901: Unraveling MEK Inhibition in Melanoma and Beyond

  2026-01-20

  Explore how PD0325901, a potent selective MEK inhibitor, advances cancer research through precise RAS/RAF/MEK/ERK pathway inhibition and innovative applications in cell differentiation. Discover new scientific insights and translational opportunities in oncology and melanoma studies.

227 records 16/16 page Previous First page 上5页 16